ストックスクリーナーアプリを入手
11.93
7.96%
0.88
前日終値:
$11.05
開ける：
$11.18
24時間の取引高:
2.17M
Relative Volume:
1.16
時価総額：
$806.10M
収益：
$796.00M
当期純損益:
$-136.49M
株価収益率:
-5.7081
EPS:
-2.09
ネットキャッシュフロー:
$-64.24M
1週間 パフォーマンス:
+10.26%
1か月 パフォーマンス:
-22.08%
6か月 パフォーマンス:
-61.52%
1年 パフォーマンス:
-71.92%
1日の値動き範囲:
$11.16
$12.08
1週間の範囲:
$10.25
$12.08
52週間の値動き範囲:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
11.93 | 732.45M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Sirius XM, Lovesac, Rogers, Tandem Diabetes, and Altice Shares Are Falling, What You Need To Know - Yahoo Finance
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Tandem Diabetes: Lowering Our Fair Value Estimate Significantly on Signs of Softness - Morningstar
Commercial and Competitive Headwinds to Delay Tandem's Shift to Positive Profits - Morningstar
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care Inc. Forms Bullish Flag — Upside AheadJuly 2025 Setups & Fast Moving Market Watchlists - metal.it
Software correction coming for faulty insulin pumps - MSN
Why Tandem Diabetes Care Inc. stock attracts strong analyst attentionJuly 2025 Rallies & Weekly High Return Forecasts - thegnnews.com
What is Tandem Diabetes Care Inc.’s valuation compared to sector - kangso.co.kr
What’s the recovery path for long term holders of Tandem Diabetes Care Inc. - Newser
Will Tandem Diabetes Care Inc. continue its uptrendCPI Data & Weekly Return Optimization Plans - Newser
Reversal indicators forming on Tandem Diabetes Care Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - Newser
Technical analysis overview for Tandem Diabetes Care Inc. stockMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
Trend analysis for Tandem Diabetes Care Inc. this week2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
PNC Financial Services Group Inc. Sells 3,004 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Relative strength of Tandem Diabetes Care Inc. in sector analysisRate Hike & High Accuracy Buy Signal Tips - Newser
Analyzing drawdowns of Tandem Diabetes Care Inc. with statistical toolsWeekly Volume Report & Capital Protection Trade Alerts - Newser
Price momentum metrics for Tandem Diabetes Care Inc. explainedTrade Volume Report & Weekly Return Optimization Alerts - Newser
What makes Tandem Diabetes Care Inc. stock price move sharplyOptions Play & High Accuracy Trade Signal Alerts - Newser
What does recent volatility data suggest for Tandem Diabetes Care Inc.July 2025 Action & Free Long-Term Investment Growth Plans - Newser
Watch for Bullish Crossover in Tandem Diabetes Care Inc.July 2025 Weekly Recap & Accurate Trade Setup Notifications - sundaytimes.kr
Published on: 2025-08-15 18:45:11 - kangso.co.kr
Tandem Diabetes upgraded at Citi on risk-reward setup - MSN
Will Tandem Diabetes Care Inc. outperform the marketJuly 2025 Technicals & Technical Pattern Alert System - Newser
Tandem Diabetes Care’s SWOT analysis: stock faces challenges amid competitive pressures - Investing.com Australia
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Globe and Mail
FDA Warns of Dangerous Error in Popular Insulin Pump Linked to 700 Adverse Events - Prevention
Intraday Charts Show Spike in Tandem Diabetes Care Inc. ActivityDay Trade & High Win Rate Trade Tips - thegnnews.com
FDA clearances: Imris, Daxor Corp., Tandem Diabetes Care - Modern Healthcare
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Rating of “Hold” by Brokerages - Defense World
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The Globe and Mail
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance
Diabetes Warning Issued Over Insulin Pump Error - Newsweek
Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating - TipRanks
5 Insightful Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
Published on: 2025-08-13 16:11:40 - 선데이타임즈
Lake Street Capital Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Hold - Defense World
Tandem Diabetes Care: Navigating Volatility and Innovation in a Polarized Market - AInvest
Tandem Diabetes' Recent Surge: Is This the Start of a Long-Term Rally or a Short-Lived Rebound? - AInvest
Tandem Diabetes Care Shares Rise After Upgrade From Citigroup - MarketScreener
Tandem Diabetes upgraded to Neutral by Citi, citing shift in risk-reward setup - AInvest
Tandem Diabetes stock upgraded at Citi (TNDM:NASDAQ) - Seeking Alpha
Tandem Diabetes at Canaccord Conference: Strategic Shifts and Market Focus - Investing.com Canada
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - Yahoo Finance
Tandem Diabetes Care shares rise 7.46% intraday after Citigroup upgrades stock to Neutral. - AInvest
Tandem Diabetes Care Stock (TNDM) Opinions on Q2 2025 Earnings Miss - Quiver Quantitative
Citigroup Upgrades Tandem Diabetes Care to Neutral From Sell, Adjusts Price Target to $10.35 From $10 - MarketScreener
Citi Upgrades Tandem Diabetes Care to Neutral, Raises PT to $10.35 - AInvest
TNDM Q2 Deep Dive: Margin Pressures and Strategic Shifts Offset Sales Growth - ca.finance.yahoo.com
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.6% on Analyst Downgrade - Defense World
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
Tandem Diabetes Care Inc (TNDM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '25 |
Option Exercise |
0.00 |
14,545 |
0 |
25,254 |
| Carpenter Rick | Chief Technology Officer |
Jun 16 '25 |
Option Exercise |
0.00 |
406 |
0 |
21,426 |
0.89%
大文字化:
|
ボリューム (24 時間):